Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Sandra Gallach García"'
Autor:
Marina Meri-Abad, Andrea Moreno-Manuel, Sandra Gallach García, Silvia Calabuig-Fariñas, Rafael Sirera Pérez, Carlos Camps Herrero, Eloisa Jantus-Lewintre
Publikováno v:
Critical Reviews in Oncology/Hematology. 182:103891
Despite the durable responses provided by the introduction of checkpoint inhibitors in advanced Non-Small Cell Lung Cancer (NSCLC) without actionable targets in a subset of patients, a large proportion of them will progress after immunotherapy. Progr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9d7bb39761cba7ff990bd5fd04baf58
https://doi.org/10.1016/j.critrevonc.2022.103891
https://doi.org/10.1016/j.critrevonc.2022.103891
Autor:
Sandra Gallach García
Publikováno v:
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
instname
instname
Lung cancer is the leading cause of death cancer-related worldwide, and is the third most common cancer type. The non-small cell lung cancer (NSCLC) comprises almost 85% of all lung cancers and the 5-year survival rate remains poor. The microRNAs (mi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30fb823b1043cd7f5b8e1e20fffe2322
http://hdl.handle.net/10251/90428
http://hdl.handle.net/10251/90428
